Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: J Hepatol. 2012 Feb 9;57(1):84–91. doi: 10.1016/j.jhep.2012.01.018

Figure 4. Comparison of inhibitory effect of SAHA and gemcitabine to PCI-24781 on the cell viability of human BTC cells (A and B) and Western blot analysis (C and D).

Figure 4

Cells were treated with PCI-24781, SAHA, and gemcitabine for 72, and 18 hours for the cell viability and Western blot analysis, respectively. Line graphs show cell viability (cell number of non-treated cells =100%) at various doses of PCI-24781, SAHA, and gemcitabine 72 hours after the treatment.